Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1938040
Reference Type
Journal Article
Subtype
Review
Title
Neuroimaging of toxic and metabolic disorders
Author(s)
Arora, A; Neema, M; Stankiewicz, J; Guss, ZD; Guss, JG; Prockop, L; Bakshi, R
Year
2008
Is Peer Reviewed?
1
Journal
Seminars in Neurology
ISSN:
0271-8235
EISSN:
1098-9021
Volume
28
Issue
4
Page Numbers
495-510
Language
English
PMID
18843577
DOI
10.1055/s-0028-1083684
Web of Science Id
WOS:000260171100010
Abstract
Imaging of the brain, magnetic resonance imaging (MRI) in particular, is a key adjunctive tool in the diagnosis and management of toxic-metabolic disorders such as alcoholism, mitochondrial encephalopathies, disorders of iron or copper metabolism, exposure to carbon monoxide, radiotherapy, immunosuppressive agents, toluene, and recreational drugs. In this article, we review the neuroimaging findings of common toxic and metabolic disorders focusing on the role of conventional MRI. We also consider advanced imaging methods, such as magnetic resonance spectroscopy, diffusion MRI, and positron emission tomography. We hope this article will prove useful to trainees and practitioners in the clinical and imaging fields of the neurosciences.
Keywords
Toxin exposure; metabolic disorders; MRI; brain; neurotoxicity
Tags
•
Trimethylbenzenes (Interagency Science Discussion Draft)
Literature Search for Related Compounds
Cited
Considered
Cited August 2016
Cited Toxicological Review
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity